Bioselect® from Alzchem makes important contribution to cancer diagnostics
Alzchem Group AG, an internationally active specialty chemicals company headquartered in Trostberg, Bavaria, has established itself as a major supplier of products related to cancer diagnostics.
With its Bioselect® products guanidine thiocyanate and guanidine hydrochloride, the company offers innovative solutions for the effective detection and investigation of cancer.
The application of the two products has proven to be extremely successful, particularly in the preparation of blood samples for cancer testing. The Bioselect® guanidine salts play a crucial role in the isolation of DNA, which is then tested for changes in the genetic material. Alzchem already supplies guanidine salts to the largest companies active in cancer diagnostics. For example, the product Bioselect® guanidine thiocyanate is part of a diagnostic kit specifically designed for bladder cancer diagnosis.
The state-of-the-art production processes and the resulting quality as well as the diverse application properties of the basic medical products have proven to be indispensable and have contributed to significantly improving the accuracy and efficiency in cancer diagnostics. Also, the security of supply as well as the offer to also produce customised products has led to Alzchem being a preferred partner for companies.
We ACT - Alzchem trades in a one hundred percent, backward integrated production "Made in Germany".
Contact
Maciej Kuczynski
About Alzchem
Alzchem is a globally active specialty chemicals company that is one of the market leaders in most of its fields of activity. Alzchem benefits from the three very different global developments climate change, population growth and longer life expectancy in a unique way. Alzchem products can offer attractive solutions for achieving the resulting social goals in a multitude of different applications.
The company sees interesting growth prospects for itself in the areas of human and animal nutrition and agriculture in particular. As a result of population growth, it is necessary to achieve efficient food production. Pharmaceutical raw materials and creatine products can contribute to a healthy old age as life expectancy increases. Alzchem is facing up to the goal of sustainability arising from climate change in the field of renewable energies and across the entire company. The fields of fine chemicals and metallurgy offer just as great a perspective.
Alzchem Group AG’s broad product range includes dietary supplements, precursors for corona tests and pharmaceutical raw materials. These products are the company's response to global trends and developments. Alzchem is ideally positioned in this respect and considers itself well prepared for an environmental future and global developments.
The company employs around 1,680 people at four production sites in Germany and a plant in Sweden, as well as three sales companies in the USA, China and England. Alzchem generated Group sales of around EUR 542.2 million and EBITDA of around EUR 61.4 million in 2022.